Business
Alps Announces Closing of Business Combination with Globalink Investment Inc.
Alps ordinary shares to list on the Nasdaq under the symbol “ALPS” on October 31, 2025KUALA LUMPUR, Malaysia and NEWARK, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated biotechnology research and healthcare platform specializing in predictive, preventive, and precision medicine, and Globalink Investment Inc., a Delaware corporation and a special purpose acquisition company (“
About this update from Alps Group Inc
[{"type":"image","alt":"Alps Group Inc","displaySize":"","headline":null,"caption":"Alps Group Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":135,"url":"https://media.zenfs.com/en/globenewswire.com/1780d61c1360908512f85687434e2349"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/AXZISgc2pcaNaKgr0DMS0g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE4OTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/1780d61c1360908512f85687434e2349","width":300,"height":135}},"lazy":false},{"type":"text","content":"Alps ordinary shares to list on the Nasdaq under the symbol “ALPS” on October 31, 2025","length":86,"tagName":"p"},{"type":"text","content":"KUALA LUMPUR, Malaysia and NEWARK, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated biotechnology research and healthcare platform specializing in predictive, preventive, and precision medicine, and Globalink Investment Inc., a Delaware corporation and a special purpose acquisition company (“Globalink”), today jointly announced the successful completion (“Closing”) of their previously announced business combination (“Business Combination”).","length":565,"tagName":"p"},{"type":"text","content":"The Business Combination was effected pursuant to the Amended and Restated Merger Agreement, originally dated January 30, 2024, as subsequently amended and restated on May 20, 2024, and further amended on March 6, 2025, April 18, 2025, and September 27, 2025 by and among Globalink, Alps Group, Alps Holdco, Alps Biosciences Merger Sub (“Merger Sub”), GL Sponsor LLC (as Parent Representative), and Dr. Tham Seng Kong (as Seller Representative).","length":445,"tagName":"p"},{"type":"text","content":"The transaction, which was approved by Globalink’s stockholders on October 7, 2025, was completed through a two-step merger process comprising (1) a Redomestication Merger, pursuant to which Globalink merged with and into Alps Group, with Alps Group continuing as the surviving publicly traded entity, and (2) an Acquisition Merger, completed immediately thereafter, whereby Merger Sub merged with and into Alps Holdco, resulting in Alps Holdco continuing as the surviving entity and becoming a wholly owned subsidiary of Alps Group.","length":533,"tagName":"p"},{"type":"text","content"...